{"id":"ipv-ssi","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains chemically inactivated (killed) poliovirus particles from serotypes 1, 2, and 3. When administered, it triggers both humoral (antibody) and cellular immune responses without causing disease, providing protection against poliomyelitis infection. This formulation is produced by Statens Serum Institut and represents a standard immunization approach for polio prevention.","oneSentence":"IPV SSI is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:11.532Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Poliomyelitis prevention in infants, children, and adults"}]},"trialDetails":[{"nctId":"NCT06375876","phase":"NA","title":"Single Session Intervention to Promote Hope","status":"COMPLETED","sponsor":"Yale University","startDate":"2024-05-07","conditions":"Domestic Violence","enrollment":97},{"nctId":"NCT03032419","phase":"PHASE3","title":"Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months","status":"COMPLETED","sponsor":"Statens Serum Institut","startDate":"2017-02-06","conditions":"Poliomyelitis","enrollment":1002},{"nctId":"NCT03025750","phase":"PHASE3","title":"Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age","status":"COMPLETED","sponsor":"Statens Serum Institut","startDate":"2017-01-19","conditions":"Poliomyelitis","enrollment":800},{"nctId":"NCT02280447","phase":"PHASE1, PHASE2","title":"3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents","status":"COMPLETED","sponsor":"Statens Serum Institut","startDate":"2014-11-13","conditions":"Immunization, Booster","enrollment":240},{"nctId":"NCT02347423","phase":"PHASE2","title":"3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants","status":"COMPLETED","sponsor":"Statens Serum Institut","startDate":"2015-02","conditions":"Poliomyelitis","enrollment":824},{"nctId":"NCT03671616","phase":"PHASE3","title":"Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months","status":"COMPLETED","sponsor":"Statens Serum Institut","startDate":"2018-05-15","conditions":"Poliomyelitis","enrollment":666},{"nctId":"NCT00376779","phase":"PHASE2","title":"Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-10","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":450},{"nctId":"NCT02771782","phase":"PHASE4","title":"Influence of BCG on TDaP-IPV Vaccination","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2015-01","conditions":"Whooping Cough","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IPV Vaccine SSI"],"phase":"phase_3","status":"active","brandName":"IPV SSI","genericName":"IPV SSI","companyName":"Statens Serum Institut","companyId":"statens-serum-institut","modality":"Biologic","firstApprovalDate":"","aiSummary":"IPV SSI is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes. Used for Poliomyelitis prevention in infants, children, and adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}